Company intelligence / Profile preview
Suzhou Pharmavan Cancer Research Center
Suzhou, Jiangsu, Chinapharmavan.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Pharmavan is a clinical-stage biotechnology company based in Suzhou, China, dedicated to the discovery and development of innovative small molecule therapeutics for oncology. The company primarily focuses on the DNA damage response (DDR) pathway, utilizing synthetic lethality principles to target cancer cells. Its lead clinical candidate, PV-001, is a potent and selective PARP inhibitor currently being evaluated in Phase 1/2 trials for various advanced solid tumors. Pharmavan leverages its internal R&D center, often referred to as the Suzhou Pharmavan Cancer Research Center, to advance a pipeline of targeted therapies designed to address significant unmet needs in cancer care.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Beyond the preview
Go deeper on Suzhou Pharmavan Cancer Research Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suzhou Pharmavan Cancer Research Center.